MDXH
MDXH
NASDAQ · Biotechnology

Mdxhealth

$0.84
-0.01 (-1.14%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +2,192.4% upside
Low Target $16.83
Average Target $19.24
High Target $29.48
Current Price $0.84
Current
$0.84
Target
$19.24
$16.83 $19.24 avg $29.48
Scenario Analysis
Bear Case
$16.83
1,905.2%
Low target
Base Case
$19.24
+2,192.4%
Avg target
Bull Case
$29.48
+3,412.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$5.33
-84.3% from high
52-Week Low
$0.94
+-10.7% from low
Target vs 52W High
$19.24
+261.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +20.5%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.2%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +178.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.1%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -88.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -23.9%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.0%